MedDataX Logo

Insulin Versus Hyaluronic Acid in Management of Periodontal Defects

NCT ID: NCT05746676

Last Updated: 2023-02-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-12

Study Completion Date

2023-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

in this study, insulin and hyaluronic acid will be used after open flap debridement in treatment of periodontal defects. outcome will be evaluated clinically and radiographically

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

n this study, insulin versus hyaluronic acid will be used after open flap debridement in treatment of periodontal defects. outcome will be evaluated clinically and radiographically after a follow up period

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Periodontal Diseases Periodontal Pocket

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

periodontitis insulin regeneration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group 1

Group Type ACTIVE_COMPARATOR

Insulin

Intervention Type DRUG

in treatment of periodontal defects

group 2

Group Type ACTIVE_COMPARATOR

Hyaluronic acid

Intervention Type DRUG

in treatment of periodontal defects

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Insulin

in treatment of periodontal defects

Intervention Type DRUG

Hyaluronic acid

in treatment of periodontal defects

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients diagnosed with periodontitis

Exclusion Criteria

* patients with systemic illness that contraindicate periodontal surgery
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

October University for Modern Sciences and Arts

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Naglaa Elwakeel

professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Al-Azhar University, Faculty of Dentistry

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Naglaa El-Wakeel, Prof.

Role: CONTACT

Phone: +2 01001757761

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Inas Motawe, prof

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P-ME-23-01

Identifier Type: -

Identifier Source: org_study_id